• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Formulary
    • Exclusives
    • Top Companies
    • Raw Materials
    • End-User
    • Packaging
    • Directories
    • Events
    • Jobs
    • More
  • Magazine
  • News
  • Formulary
  • Exclusives
  • Top Companies
  • Raw Materials
  • End-User
  • Packaging
  • Directories
  • Events
  • Jobs
  • Current / Back Issues
    Features
    Columns
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Stepping into the Spotlight for 2021

    The Independent Beauty Association Supports Sensible Reform

    Essential Workers

    A Clean Commitment

    Deliver & Delight
    Online Exclusives
    Association News
    Breaking News
    Financial News
    Industry News
    International
    Marketing News
    New Products
    News Front
    Packaging News
    Patents
    Personnel
    Regulations
    Snapshots
    Top News
    Live From Shows
    Top News
    P&G, L'Oréal & Amorepacific Make News at CES

    Three Form Vertical Beauty Alliance

    Amyris Named a Top Social & Environmental Impact Company

    L'Oréal Bans Animal Hair in Brushes

    Ashland Launches Antaron ECo Gel
    Blog
    Online Exclusives
    Infographics
    Podcasts
    Whitepapers
    Videos
    Expert's Opinion
    HappiTV
    eBook
    Surveys
    International Top 30 Report
    Top 50 Report
    Top Companies
    16. Sun Products

    46. Too faced

    The Top 50 Report

    23. PZ Cussons

    20. Oriflame
    Actives
    Functional Ingredients
    Pigments
    Polymers
    Preservatives
    Surfactants

    P&G, L'Oréal & Amorepacific Make News at CES

    Amyris Named a Top Social & Environmental Impact Company

    Coming Clean About Clean Beauty

    Isosorbide Di-(Linoleate/Oleate) Treats Xerotic Pruritic Skin

    Nu Skin Launches ‘Clean’ Formula Line
    Air Care/Environmental Fragrance
    AP/Deo
    Color Cosmetics
    Disinfectants
    Fine Fragrance
    Hair Care
    Household Cleaning
    I&I Marketplace
    Laundry Care
    Oral Care
    OTC/Medicated
    Packaging
    Personal Cleansers
    Skin Care
    Sun Care
    Testing

    P&G, L'Oréal & Amorepacific Make News at CES

    Three Form Vertical Beauty Alliance

    Amyris Named a Top Social & Environmental Impact Company

    L'Oréal Bans Animal Hair in Brushes

    Coming Clean About Clean Beauty
    Lab Equipment
    Mixing
    Packaging
    Testing

    Three Form Vertical Beauty Alliance

    Logo Design Trends for 2021 & Beyond

    Coming Clean About Stink

    Henkel Reaches Sustainable Packaging Milestone

    Ross Designs Mixer for Increased Shear
    Contract Manufacturing / Private Label Directory
    Buyer's Guide
    Add New Company
    Corporate Profiles
    International Buyers Guide Companies
    Sabinsa Cosmetics, a division of Sabinsa Corporation

    Comprehensive Research Group Inc.

    Siltech Corporation

    Jeen International

    Praan Naturals
    Live From Shows
    Meetings
    Webinars
    Snapshots
    • Magazine
      • Current / Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Formulary
    • Directories
      • Buyer's Guide
      • Contract Manufacturing / Private Label Directory
      • Corporate Profiles
      • Add Your Company
    • Raw Materials
      • Actives
      • Functional Ingredients
      • Pigments
      • Polymers
      • Preservatives
      • Surfactants
    • End-User
      • Air Care/Environmental Fragrance
      • AP/Deo
      • Color Cosmetics
      • Disinfectants
      • Fine Fragrance
      • Hair Care
      • Household Cleaning
      • I&I Marketplace
      • Laundry Care
      • Oral Care
      • OTC/Medicated
      • Packaging
      • Personal Cleansers
      • Skin Care
      • Sun Care
      • Testing
    • Packaging
      • Lab Equipment
      • Mixing
      • Packaging
      • Testing
    • Top Companies
      • International Top 30 Report
      • Top 50 Report
    • Online Exclusives
    • Experts Opinion
    • Slideshows
    • HappiTV
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Blog
    • Whitepapers
    • Surveys
      • R & D Salary Survey
      • Sales & Marketing Salary Survey
    • Job Banks
    • Events
      • Industry Events
      • Live from show Events
      • Webinars
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Claims Substantiation

    Are In Vitro Results Enough To Make Product Claims?

    Use the data only after considering study limitations.

    Related CONTENT
    • Farmasi Expands Age Reversist Line
    • Beauty Industry Veteran Launches Skin Care Line
    • Alpyn Beauty Has Success with Peel
    • BYBI Launches in Target
    • Target cellular proteostasis for an anti-aging performance
    Nava Dayan, Dr. Nava Dayan LLC07.03.17
    The ability to isolate and maintain cells in an artificial environment presents a major contribution to the advancement of research and is extensively utilized by the scientific community. In vitro assays attempt to develop a hypothesis for a compound’s or formulation’s potential mode of action. In the pharmaceutical industry, those are referred to as “Pharmacodynamic models.” These studies enable researchers to track a variety of cellular and tissue biomarkers: genes, gene expression, proteins and peptides such as receptors, enzymes and cytokines and lipids. They can also assist with understanding threshold effect on viability, cell morphology and proliferation patterns.


    But the operation of in vitro assays is remote from real life exposure of the whole human body and the skin as an organ; therefore, any determination of mode of action drawn from only such studies and explained as an ultimate activity may be misleading. Human exposure studies should follow to substantiate a potential claim. Complex organs such as skin present endless opportunities for possible biochemical paths, many unknown; sometimes the clinical effect cannot be fully elucidated and connected to changes in biomarkers or cell behavior patterns.


    When working with a culture, one creates a selective abnormal controlled microenvironment composed of limited components that is revised and isolated from the body. Unless further substantiated by a human exposure study, results obtained from such assays should be presented as an opportunity only and not as a decisive “discovery of mode of action” used in an advertisement to the general public. The study, if conducted in a scientifically savvy manner, can be presented as a hypothesis in scientific journal publications so the reader can employ knowledge and judgment. The paper should compare data obtained to other relevant results from former study groups. When presented in such a manner, it is not deterministic and is exposed to criticism by the proper scientific community. But such assessment is not feasible when presented to the average consumer. When a layman is presented with data that points, for example, to an enzymatic activity that is explained as beneficial, he may be mistaken to think that the biochemical path presented is the only one that exists for the purpose of use and therefore ultimately impacts organ and/or body health. As scientists we know that in nature every molecule has more than one function and its action is highly affected by its environment. For example, the paths that work to prevent cancer can actually promote cancer if abused and manipulated. It’s all about the circumstances, and circumstances in cell culture assays are controlled by scientists working on the study.


    In skin care research, cells used in a cell culture can be of three main types:
    • Monolayer—composed of one cell type such as fibroblasts or keratinocytes;
    • Co-culture—two or more cell types such as keratinocytes-melanocytes or fibroblasts- mast cells;
    • Artificial model—one or more cell types constructed in a three-dimensional shape to have closer resemblance to the skin as an organ.


    These cells, obtained from skin explants, are detached from their normal environment and placed in a new artificial environment. They are not influenced by other cells, blood circulation, lymphatic system and other factors. In culture, cells are kept in sterile protected conditions and removed of the microbiome, pollutants and solar or other radiation. Skin biota is known to be a key in health maintenance and is involved in innate immunity. In many cell cultures, antibiotics are added to the media to prevent microbial growth and contamination.


    The three-dimensional model may be preferred as it is most similar to real skin than monolayers or co-cultures. However, it still maintains a few key limitations: its barrier is typically weaker; it does not contain key skin structures such as sweat glands and hair follicles, it is not connected to the circulatory or the lymphatic system, it does not exfoliate, and it lacks other skin cells such as Langerhans, melanocytes, sebocytes, merkel and mast cells as well as innervation.


    Adapt or Die


    Cell culture models undergo adaptation in order to survive through passages that allow for repeat use. This process is called “sub-culturing” also referred to as “passaging;” i.e., when cells are grown and proliferate, aliquot of cells from existing culture is passed and seeded on an empty culture plate to proliferate again and generate another ground for testing. This procedure involves the removal of the medium and transfer of cells from a previous culture into fresh growth medium. It enables the propagation of the cell line or cell strain. Cell passaging is conducted by the scientist working in the lab and should be done according to a strict schedule to ensure reproducible behavior and cell health. Cells in such cultures are immortalized. An immortalized cell line refers to a population of cells that is separated from an organ and undergoes modification. If these cells are not modified, they will not proliferate indefinitely. In fact, if not immortalized, due to normal mutation they undergo cellular senescence, aging at the cell level that enables maintenance of metabolism but halts proliferation.


    Normal senescence ceases cellular division and the culture dies. Non-immortalized cells, called primary cells, have a finite lifespan. They more closely resemble normal skin cells, so they would die after a certain period of time in culture. To repeat experimentation with primary cells, scientists must obtain skin explants every time an experiment is run and isolate the cells from the explant. The process is not only complicated and expensive, it also presents genetic inconsistency between cell cultures in experiments.


    As explained, to allow the use of cell lines for long durations, the cells undergo mutation for immortality. Immortal cell lines are an important research tool. They grant genetic batch-to-batch consistency and passages in which they are seeded to proliferate for continuous testing. However, these cells are different from cells in the body. They are grown in an artificial media, are deprived from normal cell cycle and do not communicate with other cells in the organism nor affected by other cells. In addition, while they can exhibit consistency, they do not represent the diversity that exists in real life. Most cell lines are derived from Caucasian donors, preferably infants. Such cells do not exemplify other ethnicities, variations in age, gender or lifestyle. Perhaps most of the studies conducted on human derived keratinocytes and fibroblasts are obtained from foreskin of Caucasian baby. Therefore, most of the products tested reflect activity on very narrow population and ethnicity that may not signify market population of interest. In recent years, some companies expanded their cell-line offerings to include cells obtained from various donor ages and ethnicities. This allows the selection of a model that might be a closer reflection of the population of interest.


    An Organ of Interest


    When considering skin as the organ of interest, cell line and 3D model pose yet another key limitation. The skin has a relatively strong barrier. When introduced to a cell culture, a compound comes in direct contact with the cell. Such condition may not mimic real life exposure if the compound of interest does not partition into the skin and does not reach the living epidermis or dermis. Often, even if such penetration occurs, the concentration that reaches living cells may be substantially lower when compared to that in a cell culture. In addition, when applied in vivo, the compound may undergo degradation, oxidation and metabolism that change its nature. In pharmacology, the term “bioavailability” describes a drug reaching its site of action, be it an organ, tissue or cell. If, for example, the circulatory system is the target of the drug and the drug is administered intravenously, its absorption is 100% but bioavailability may be lower since it can be rapidly metabolized or bind to blood proteins that can prevent its mobility and reach its targets. When the same drug is applied to healthy, intact skin only a fraction of the applied dose, if at all, will absorb through the skin and reach the circulation. As such both absorption and bioavailability will be reduced significantly.


    Finally, some cell lines used in in vitro assays are non-human and therefore are even more remote from human cell behavior. An example for a common cell line used for skin research is the 3T3 mouse embryo fibroblasts. This is an immortalized cell line established in 1962 by two scientists at the Department of Pathology at New York University. Today this cell line is used extensively in a variety of studies. It is considered inexpensive, fairly easy to work with and highly sensitive.


    The ability to culture cells in the lab and study their behavior under various conditions opened a universe of research opportunities. Cell culture assays greatly advanced science and medicine. These models undergo constant improvement and there is a large pool of data to learn from and draw comparisons. However, presenting data derived from such studies in marketing advertisements for the average consumer provides great disservice and undermines its scientific value to an inappropriate level. The skin care industry should continue conducting such assay to establish data on potential safety and efficacy but should use the data after considering study limitations.•


    About the Author
    Nava Dayan Ph.D. is the owner of Dr. Nava Dayan L.L.C., a skin science and research consultancy serving the pharmaceutical, cosmetic and personal care industries. She has 25 years of experience in the skin care segment, and more than 150 publication credits.

    Tel: 201-206-7341; Email: nava.dayan@verizon.net
    Related Searches
    • cell culture
    • Skin Care
    • in vitro
    • cells
    Related Knowledge Center
    • Preservatives
    • Skin Care
    • Actives
    Suggested For You
    Farmasi Expands Age Reversist Line Farmasi Expands Age Reversist Line
    Beauty Industry Veteran Launches Skin Care Line Beauty Industry Veteran Launches Skin Care Line
    Alpyn Beauty Has Success with Peel Alpyn Beauty Has Success with Peel
    BYBI Launches in Target BYBI Launches in Target
    Target cellular proteostasis for an anti-aging performance Target cellular proteostasis for an anti-aging performance
    The Invention Legacy of COVID-19 & Implications for Home & Personal Care The Invention Legacy of COVID-19 & Implications for Home & Personal Care
    Skin Care Actives  During  Inactivity Skin Care Actives During Inactivity
    Silab Launches Erisium Silab Launches Erisium
    Amorepacific Amorepacific's Anti-Aging Joint Research with KAIST
    L L'Oréal Names 2020 For Women in Science Fellows
    Vaccine for Skin Cancer Shows Promise Vaccine for Skin Cancer Shows Promise
    Innovation in Double Planetary Mixers at Ross Innovation in Double Planetary Mixers at Ross
    The Benefits of Synastol TC Explained The Benefits of Synastol TC Explained
    Humming Along Humming Along
    FDA Calls Out FDA Calls Out 'Black Salves' As Dangerous

    Related Claims Substantiation

    • Actives | Functional Ingredients | OTC/Medicated | Packaging | Skin Care | Sun Care | Testing

      Formulation Stability’s Impact on the Clinical Outcome

      ...
      Nava Dayan, Dr. Nava Dayan LLC 01.04.18

    • Actives | Color Cosmetics | Functional Ingredients | Hair Care | Personal Cleansers | Skin Care | Sun Care | Testing

      Evaluating the Efficacy of Natural Cosmetics

      ...
      Nava Dayan, Dr. Nava Dayan LLC 11.01.17

    • Skin Care | Testing

      Gender Matters in Skin Care Testing

      ...
      Nava Dayan, Dr. Nava Dayan LLC 09.01.17


    • Actives | Functional Ingredients | Skin Care | Sun Care

      Using Data from Studies Conducted by Suppliers

      ...
      Nava Dayan, Dr. Nava Dayan LLC 05.01.17

    • Color Cosmetics | Hair Care | Personal Cleansers | Skin Care | Sun Care | Testing

      Why Make Claims in the First Place?

      ...
      Nava Dayan, Dr. Nava Dayan LLC 01.06.17

    Trending
    • Amyris Named A Top Social & Environmental Impact Company
    • Formulating Liquid Laundry Detergents
    • Reusables For Consumables In The Pandemic And Beyond
    • Maybelline Unveils 'Sky High' Mascara
    • Interparfums SA To Buy Paris HQ Office
    Breaking News
    • P&G, L'Oréal & Amorepacific Make News at CES
    • Three Form Vertical Beauty Alliance
    • Amyris Named a Top Social & Environmental Impact Company
    • L'Oréal Bans Animal Hair in Brushes
    • Ashland Launches Antaron ECo Gel
    View Breaking News >
    CURRENT ISSUE

    January 2021

    • Stepping into the Spotlight for 2021
    • The Independent Beauty Association Supports Sensible Reform
    • Essential Workers
    • A Clean Commitment
    • Deliver & Delight
    • Reusables for Consumables In the Pandemic and Beyond
    • A Rebound for Beauty
    • Beauty Brands Must Prepare for a 'Decade of the Home'
    • A Societal Shift
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Brown Fat Associated with Reductions in Chronic Disease Risk
    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    P&G, L'Oréal & Amorepacific Make News at CES
    Three Form Vertical Beauty Alliance
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login